Last week, Big Molecule Watch sat down with Professor Arti Rai to discuss an article she recently co-authored, “How logically impossible patents block biosimilars.” The article, published earlier this month in the...more
8/24/2019
/ America Invents Act ,
Biosimilars ,
Food and Drug Administration (FDA) ,
Patent Applications ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prior Art ,
Purple Book ,
USPTO